山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
32期
4-6
,共3页
覃新干%罗殿中%吕自力%陈罡%苏传丽
覃新榦%囉殿中%呂自力%陳罡%囌傳麗
담신간%라전중%려자력%진강%소전려
肝癌%HepG2细胞%泛素连接酶%ARF-BP1
肝癌%HepG2細胞%汎素連接酶%ARF-BP1
간암%HepG2세포%범소련접매%ARF-BP1
hepatoma%HepG2 cell%ubiquitinligating enzyme%ARF-BP1
目的:观察ARF-BP1基因对肝癌HepG2细胞凋亡的影响,并探讨其机制。方法取对数生长期的HepG2细胞,随机分为4组。转染组采用脂质体LipofectamineTM2000包裹技术将100 nmol/L ARF-BP1 siRNA瞬时转染HepG2细胞;脂质体对照组只加脂质体,不加siRNA片段;阴性对照组转染阴性siRNA片段;空白对照组不加siRNA片段及脂质体,仅加等量培养基。采用流式细胞术检测各组细胞凋亡率,RT-PCR法检测转染组和空白对照组p53、Mcl-1 mRNA相对表达。结果转染组、脂质体对照组、阴性对照组和空白对照组的细胞凋亡率分别为27.90%±1.40%、3.33%±0.66%、3.05%±0.73%和1.64%±0.12%;转染组与其他组比较,P均<0.01;阴性对照组、脂质体对照组与空白对照组比较,P均<0.05。转染72 h后,转染组p53、Mcl-1 mRNA相对表达分别为0.29±0.08和0.23±0.04,均低于空白对照组的0.63±0.07和0.34±0.02,P<0.01、0.05。结论降低肝癌HepG2细胞ARF-BP1基因表达会促进肿瘤细胞凋亡,可能与其抑制p53、Mcl-1基因表达有关。
目的:觀察ARF-BP1基因對肝癌HepG2細胞凋亡的影響,併探討其機製。方法取對數生長期的HepG2細胞,隨機分為4組。轉染組採用脂質體LipofectamineTM2000包裹技術將100 nmol/L ARF-BP1 siRNA瞬時轉染HepG2細胞;脂質體對照組隻加脂質體,不加siRNA片段;陰性對照組轉染陰性siRNA片段;空白對照組不加siRNA片段及脂質體,僅加等量培養基。採用流式細胞術檢測各組細胞凋亡率,RT-PCR法檢測轉染組和空白對照組p53、Mcl-1 mRNA相對錶達。結果轉染組、脂質體對照組、陰性對照組和空白對照組的細胞凋亡率分彆為27.90%±1.40%、3.33%±0.66%、3.05%±0.73%和1.64%±0.12%;轉染組與其他組比較,P均<0.01;陰性對照組、脂質體對照組與空白對照組比較,P均<0.05。轉染72 h後,轉染組p53、Mcl-1 mRNA相對錶達分彆為0.29±0.08和0.23±0.04,均低于空白對照組的0.63±0.07和0.34±0.02,P<0.01、0.05。結論降低肝癌HepG2細胞ARF-BP1基因錶達會促進腫瘤細胞凋亡,可能與其抑製p53、Mcl-1基因錶達有關。
목적:관찰ARF-BP1기인대간암HepG2세포조망적영향,병탐토기궤제。방법취대수생장기적HepG2세포,수궤분위4조。전염조채용지질체LipofectamineTM2000포과기술장100 nmol/L ARF-BP1 siRNA순시전염HepG2세포;지질체대조조지가지질체,불가siRNA편단;음성대조조전염음성siRNA편단;공백대조조불가siRNA편단급지질체,부가등량배양기。채용류식세포술검측각조세포조망솔,RT-PCR법검측전염조화공백대조조p53、Mcl-1 mRNA상대표체。결과전염조、지질체대조조、음성대조조화공백대조조적세포조망솔분별위27.90%±1.40%、3.33%±0.66%、3.05%±0.73%화1.64%±0.12%;전염조여기타조비교,P균<0.01;음성대조조、지질체대조조여공백대조조비교,P균<0.05。전염72 h후,전염조p53、Mcl-1 mRNA상대표체분별위0.29±0.08화0.23±0.04,균저우공백대조조적0.63±0.07화0.34±0.02,P<0.01、0.05。결론강저간암HepG2세포ARF-BP1기인표체회촉진종류세포조망,가능여기억제p53、Mcl-1기인표체유관。
Objective To investigate the effect of ARF-BP1 gene on apoptosis of hepatoma HepG2 cells, and to ex-plore its mechanism.Methods HepG2 cells in logarithmic growth phase were randomly divided into 4 groups.Transfec-tion group was transfected translently by 100 nmol/L ARF-BP1 siRNA with LipofectamineTM 2000;liposome control group was only added liposomes; negative control group was transfected by negative siRNA fragments; blank control group was added the same amount of medium only, without siRNA fragments and liposomes.The flow cytometry was utilized to detect cells apoptosis rate of 4 groups; RT-PCR was used to detect the relative expression of p53, Mcl-1 mRNA in transfection group and blank control group.Results The apoptosis rate of transfection group, liposome control group, negative control group and blank control group were 27.90%±1.40%, 3.33%±0.66%, 3.05%±0.73% and 1.64%±0.12%, re-spectively;transfection group compared with other groups, all P<0.01; negative control group and liposome group com-pared with the control group, both P<0.05.72 h after transfection, p53, Mcl-1 mRNA relative expression in transfection group were 0.29 ±0.08 and 0.23 ±0.04, significantly lower than those in the blank control group ( P<0.01 and P<0.05).Conclusion Reduced ARF-BP1 gene expression in HepG2 cells can promote tumor cell apoptosis, which maybe correlate with inhibition of p53, Mcl-1 expression.